About this trial
The aim of this observational study was to understand the effect of radiofrequency ablation on subjects with moderate to severe gastric atrophy with enterocolitis with or without low-grade intraepithelial neoplasia who underwent radiofrequency ablation. The main question it aims to answer is:
Does radiofrequency ablation therapy reduce gastric mucosal atrophy and enterosis in subjects with moderate to severe gastric atrophy with enterosis with or without low-grade intraepithelial neoplasia?
Eligibility criteria
Qualifiers
Age 18-70 years old, male or female.
Patients who had undergone gastroscopy within 3 months prior to inclusion, and whose histologic diagnosis of chronic gastritis was histologically atrophic enterocolitis graded at moderate-to-severe with or without low-grade intraepithelial neoplasia.
Patients who had undergone gastroscopy within 3 months prior to inclusion, and whose OLGA (atrophic grading and staging criteria for chronic gastritis) or OLGIM (enteric grading and staging criteria for chronic gastritis) staging criteria had reached moderately severe.
Helicobacter pylori negative.
Disqualifiers
Pregnant or lactating women.
Previous history of malignant tumors of the digestive tract or history of gastrointestinal surgery.
Malignant tumors of other organs, coagulation disorders, cardiopulmonary insufficiency, hepatic and renal insufficiency, etc.
Those who are unable or unwilling to sign the informed consent form.
Trial design
Treatments tested in this trial
- Radiofrequency ablation alone
Treatment groups
Locations
Sponsors and collaborators
Xiuli Zuo
Lead sponsor
Shandong University
Sponsor institution